For years aspirin has been marketed as a key prevention step for heart attack or stroke, but the FDA says that should not be the case. Especially for people with no history of cardiovascular disease. Just last week, the FDA turned down a request from German drugmaker Bayer AG to change the labeling to market the drug to people with no heart attack risk. The FDA says that for these people "the benefit has not been established but risks, such as dangerous bleeding in the brain or stomach, are still present." Aspirin is used widely for the primary prevention of heart attack and stroke. In fact many physicians prescribe it and the American Heart Association currently supports its use for primary prevention when recommended by a physician in high risk patients. But there is an increased risk of internal bleeding by those taking daily aspirin therapy. The best advice is to check with your doctor for the best dose and frequency for aspirin or any medication, that will provide the greatest benefits with the least amount of side effects.